UAB Ritamum pharma Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 1,431,894 |
| 286,379 |
| 597,242 |
| 507,317 |
| 101,463 |
| 64.17 |
| 35.43 |
| 471,216 |
| 139,398 |
| 12,002 |
| 598,273 |
| 2023 |
|---|
| 1,140,177 |
| 228,035 |
| 366,068 |
| 310,559 |
| 62,112 |
| 68.99 |
| 27.24 |
| 466,950 |
| 115,426 |
| 17,860 |
| 563,985 |
| 2024 |
|---|
| 1,168,280 |
| 232,725 |
| 444,618 |
| 376,364 |
| 74,973 |
| 60.71 |
| 32.22 |
| 566,844 |
| 114,884 |
| 13,134 |
| 667,934 |
Register and
explore Okredo data| 2024 |
|---|
| 1,168,280 |
| 232,725 |
| 444,618 |
| 376,364 |
| 74,973 |
| 60.71 |
| 32.22 |
| 566,844 |
| 114,884 |
| 13,134 |
| 667,934 |
Register and
explore Okredo data2024
Turnover (€)
1,168,280 €
2 % *
Sales per employee (€)
232,725 €2 % *
Profit before tax (€)
444,618 €21 % *
Net Profit (€)
376,364 €21 % *
Profit per employee (€)
74,973 €21 % *
Total profitability (%)
60.71 %
-12.00 % *
Net profitability (%)
32.22 %18.28 % *
Equity (€)
566,844 €21 % *
Amounts Payable And Liabilities (€)
114,884 €
0 % *
Non-current Assets (€)
13,134 €-26 % *
CurrentAssets (€)
667,934 €
18 % *